Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Hisse Senetlerindeki Sıralama #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Hisse Fiyatı
$0.00185055
Piyasa Değeri
$48.29K
Değişim (1 gün)
-3.55%
Değişim (1 yıl)
30.31%
Ülke
GB
Ticaret Nuformix plc (NFX)

Kategori

Nuformix plc (NFX) için P/S oranı
September 2026 itibarıyla P/S oranı TTM: 0.00
Nuformix plc şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 0.00'dir. 2024 yılının sonunda şirketin P/S oranı 0.00 idi.
Nuformix plc için P/S oranı geçmişi 2014 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH